Follow
Sabrina Lusvarghi, PhD
Sabrina Lusvarghi, PhD
Verified email at fda.hhs.gov
Title
Cited by
Cited by
Year
Griffithsin: an antiviral lectin with outstanding therapeutic potential
S Lusvarghi, CA Bewley
Viruses 8 (10), 296, 2016
1432016
Synthesis, stereoelectronic characterization and antiparasitic activity of new 1-benzenesulfonyl-2-methyl-1, 2, 3, 4-tetrahydroquinolines
RJ Pagliero, S Lusvarghi, AB Pierini, R Brun, MR Mazzieri
Bioorganic & medicinal chemistry 18 (1), 142-150, 2010
852010
SARS-CoV-2 BA. 1 variant is neutralized by vaccine booster–elicited serum but evades most convalescent serum and therapeutic antibodies
S Lusvarghi, SD Pollett, SN Neerukonda, W Wang, R Wang, R Vassell, ...
Science Translational Medicine 14 (645), eabn8543, 2022
782022
Loop and backbone modifications of peptide nucleic acid improve g-quadruplex binding selectivity
S Lusvarghi, CT Murphy, S Roy, FA Tanious, I Sacui, WD Wilson, DH Ly, ...
Journal of the American Chemical Society 131 (51), 18415-18424, 2009
672009
Targeted isolation of antibodies directed against major sites of SIV Env vulnerability
RD Mason, HC Welles, C Adams, BK Chakrabarti, J Gorman, T Zhou, ...
PLoS Pathogens 12 (4), e1005537, 2016
612016
Avapritinib: a selective inhibitor of KIT and PDGFRα that reverses ABCB1 and ABCG2-mediated multidrug resistance in cancer cell lines
CP Wu, S Lusvarghi, JC Wang, SH Hsiao, YH Huang, TH Hung, ...
Molecular pharmaceutics 16 (7), 3040-3052, 2019
592019
HIV-1 gp120 as a therapeutic target: navigating a moving labyrinth
P Acharya, S Lusvarghi, CA Bewley, PD Kwong
Expert opinion on therapeutic targets 19 (6), 765-783, 2015
512015
SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster
S Lusvarghi, SD Pollett, SN Neerukonda, W Wang, R Wang, R Vassell, ...
BioRxiv, 2021
412021
Tivantinib, A c-met inhibitor in clinical trials, is susceptible to ABCG2-mediated drug resistance
ZX Wu, Y Yang, QX Teng, JQ Wang, ZN Lei, JQ Wang, S Lusvarghi, ...
Cancers 12 (1), 186, 2020
392020
The HIV-2 Rev-response element: determining secondary structure and defining folding intermediates
S Lusvarghi, J Sztuba-Solinska, KJ Purzycka, GT Pauly, JW Rausch, ...
Nucleic acids research 41 (13), 6637-6649, 2013
372013
The FLT3 inhibitor midostaurin selectively resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents
SH Hsiao, S Lusvarghi, YH Huang, SV Ambudkar, SC Hsu, CP Wu
Cancer letters 445, 34-44, 2019
362019
Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro
Y Yang, N Ji, QX Teng, CY Cai, JQ Wang, ZX Wu, ZN Lei, S Lusvarghi, ...
Frontiers in oncology 10, 700, 2020
342020
Retrotransposon Ty1 RNA contains a 5′-terminal long-range pseudoknot required for efficient reverse transcription
Q Huang, KJ Purzycka, S Lusvarghi, D Li, SFJ LeGrice, JD Boeke
Rna 19 (3), 320-332, 2013
342013
Exploring Ty1 retrotransposon RNA structure within virus-like particles
KJ Purzycka, M Legiewicz, E Matsuda, LD Eizentstat, S Lusvarghi, A Saha, ...
Nucleic acids research 41 (1), 463-473, 2013
342013
Reversing the direction of drug transport mediated by the human multidrug transporter P-glycoprotein
A Sajid, S Lusvarghi, M Murakami, EE Chufan, B Abel, MM Gottesman, ...
Proceedings of the National Academy of Sciences 117 (47), 29609-29617, 2020
322020
Key substitutions in the spike protein of SARS-CoV-2 variants can predict resistance to monoclonal antibodies, but other substitutions can modify the effects
S Lusvarghi, W Wang, R Herrup, SN Neerukonda, R Vassell, L Bentley, ...
Journal of virology 96 (1), e01110-21, 2022
312022
Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history
W Wang, S Lusvarghi, R Subramanian, NJ Epsi, R Wang, E Goguet, ...
Cell host & microbe 30 (12), 1745-1758. e7, 2022
302022
The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants
S Rothenberger, DL Hurdiss, M Walser, F Malvezzi, J Mayor, S Ryter, ...
Nature biotechnology 40 (12), 1845-1854, 2022
302022
Multidrug transporters: recent insights from cryo-electron microscopy-derived atomic structures and animal models
S Lusvarghi, RW Robey, MM Gottesman, SV Ambudkar
F1000Research 9, 2020
292020
Licochalcone A selectively resensitizes ABCG2-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs
CP Wu, S Lusvarghi, SH Hsiao, TC Liu, YQ Li, YH Huang, TH Hung, ...
Journal of natural products 83 (5), 1461-1472, 2020
282020
The system can't perform the operation now. Try again later.
Articles 1–20